Limongi Roberto Murillo, Feijó Eduardo Damous, Rodrigues Lopes E Silva Marlos, Akaishi Patrícia, Velasco E Cruz Antônio Augusto, Christian Pieroni-Gonçalves Allan, Pereira Filipe, Devoto Martin, Bernardini Francesco, Marques Victor, Tao Jeremiah P
Department of Ophthalmology, Federal University of Goiás, Goiânia, Brazil.
Department of Opthalmology, University of São Paulo - Ribeirão Preto, Brazil.
Ophthalmic Plast Reconstr Surg. 2020 Jan/Feb;36(1):13-16. doi: 10.1097/IOP.0000000000001435.
To report a multicenter large case series of orbital decompression for non-thyroid eye disease proptosis.
Retrospective chart review of cases of orbital decompression performed by 9 experienced orbital surgeons from different countries from 2014 to 2017 for non-thyroid eye disease proptosis. Patients were divided into 3 groups: 1) negative vector (high axial length or shallow orbit), 2) inflammatory, and 3) tumor. Types of orbital decompression and Hertel exophthalmometry (preoperative and minimum 6 months postoperative) were recorded. Charts were also assessed for serious complications. The amount of exophthalmometry improvement was recorded according to the above groups.
The analysis included 41 orbits of 29 patients (14 women and 15 men) with a mean age of 38.9 years (ranging from 9 to 74; standard deviation (SD) 15.66). There were 17 orbits of 11 patients in the negative vector group, 16 orbits of 10 patients in the inflammatory group, and 8 orbits of 8 patients in the tumor group. The mean reduction of proptosis was 2.95 mm in the negative vector group, 2.54 mm in the inflammatory group, and 5.75 mm in the tumor group. There were no serious complications.
Orbital decompression was safe and effective in reducing proptosis for non-thyroid eye disease indications in this series. The amount of exophthalmometry improvement was less in the inflammatory orbitopathy group compared with other proptosis etiology groups.Orbital decompression may have a role in improving proptosis in non-thyroid eye disease entities.
报告非甲状腺眼病所致眼球突出眼眶减压术的多中心大病例系列。
对2014年至2017年期间9位来自不同国家的经验丰富的眼眶外科医生为非甲状腺眼病所致眼球突出患者施行眼眶减压术的病例进行回顾性图表分析。患者分为3组：1）负向量组（眼轴长或眼眶浅），2）炎症组，3）肿瘤组。记录眼眶减压类型及术前和术后至少6个月的赫特尔眼球突出度测量值。对图表进行严重并发症评估。根据上述分组记录眼球突出度改善量。
分析纳入29例患者（14例女性和15例男性）的41只眼眶，平均年龄38.9岁（9至74岁；标准差15.66）。负向量组11例患者的17只眼眶，炎症组10例患者的16只眼眶，肿瘤组8例患者的8只眼眶。负向量组眼球突出平均减少2.95mm，炎症组为2.54mm，肿瘤组为5.75mm。无严重并发症。
在本系列中，眼眶减压术对非甲状腺眼病适应证所致眼球突出的减轻是安全有效的。与其他眼球突出病因组相比，炎症性眼眶病组的眼球突出度改善量较少。眼眶减压术可能在改善非甲状腺眼病实体的眼球突出方面发挥作用。
